Systemic Immune-Inflammation Index May Predict the Development of Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction
Restricted accessResearch articleFirst published online March, 2022
Systemic Immune-Inflammation Index May Predict the Development of Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction
The aim of this study was to investigate the predictive capacity of a systemic immune-inflammation index (SII) in the detection of contrast-induced nephropathy (CIN) following ST-segment elevation myocardial infarction (STEMI). A total of 477 STEMI patients were enrolled in the study. The patients were divided into 2 groups according to CIN development. A cutoff point of 5.91 for logarithm-transformed SII was identified with 73.0% sensitivity and 57.5% specificity to predict CIN following STEMI. According to a pairwise analysis of receiver operating characteristic curve analysis, the predictive power of SII in detecting CIN following STEMI was similar to that of high-sensitivity C-reactive protein and better than the neutrophil/lymphocyte ratio or platelet/lymphocyte ratio. As a result, SII can be used as one of the independent predictors of CIN after STEMI.
IbanezBJamesSAgewallS, et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–77.
2.
GuptaRGurmHSBhattDLChewDPEllisSG. Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv. 2005;64:442–8.
3.
MarenziGLauriGAssanelliE, et al.Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004;44:1780–5.
4.
WongPCYLiZGuoJZhangA. Pathophysiology of contrast-induced nephropathy. Int J Cardiol. 2012;158:186–92.
5.
LiuYTanNZhouY-L, et al.High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention. J Nephrol. 2012;25:332–40.
6.
AksoyFBaşHABağcıASavaşHB. Predictive value of oxidant and antioxidant status for contrast-induced nephropathy after percutaneous coronary intervention for ST-segment elevation myocardial infarction. Rev Port Cardiol. 2020;doi:10.1016/j.repc.2020.08.010.
7.
AgusHZKahramanSArslanC, et al.Systemic immune-inflammation index predicts mortality in infective endocarditis. J Saudi Heart Assoc. 2020;32:58.
8.
ErdoğanMErdölMAÖztürkSDurmazT. Systemic immune-inflammation index is a novel marker to predict functionally significant coronary artery stenosis. Biomark Med. 2020;14:1553–61.
9.
KimYChoiHJungSMSongJJParkYBLeeSW. Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-naïve patients with antineutrophil cytoplasmic antibody-associated vasculitis. Nephrology. 2019;24:711–7.
10.
MembersATFPiepoliMFHoesAW, et al.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol. 2016;23:NP1–NP96.
11.
ThomsenHMorcosS.Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol. 2003;76:513–8.
12.
WiJKoY-GKimJ-S, et al.Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart. 2011;97:1753–7.
13.
ParfreyPSGriffithsSMBarrettBJ, et al.Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med. 1989;320:143–9.
14.
McCulloughPAWolynRRocherLLLevinRNO’NeillWW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368–75.
15.
MuntnerPWheltonPKCoreshJKlagMJPernegerTV. Exposure to radiologic contrast media and an increased risk of treated end-stage renal disease. Am J Med Sci. 2003;326:353–9.
16.
CroninRE. Contrast-induced nephropathy: pathogenesis and prevention. Pediatric Nephrology. 2010;25:191–204.
17.
OgiMIwaseNKitamuraT, et al.Risk factors for contrast nephropathy in diabetic patients undergoing cardioangiography. Nihon Jinzo Gakkai Shi. 1993;35:161–70.
18.
RihalCSTextorSCGrillDE, et al.Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–64.
DavidsonCStaculFMcCulloughPA, et al.Contrast medium use. Am J Cardiol. 2006;98:42–58.
21.
MarenziGLauriGCampodonicoJ, et al.Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med.2006;119:155–162.
22.
MehranRAymongEDNikolskyE, et al.A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393–9.
23.
HuangYGaoYWuYLinH. Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis. Cancer Cell Int. 2020;20:1–8.
24.
GokMKurtulA. A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index. Scand Cardiovasc J. 2020;doi:10.1080/14017431.2020.1846774.
25.
EsenboğaKKurtulAYamantürkYYTanTSTutarDE. Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention. Acta Cardiol. 2021:1–8.
26.
YangYLWuCHHsuPF, et al.Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50:e13230.
27.
KelesogluSYilmazYElcıkD, et al.Systemic Immune Inflammation Index: A Novel Predictor of Contrast-Induced Nephropathy in Patients With Non-ST Segment Elevation Myocardial Infarction. Angiology. 2021:00033197211007738.
28.
AksoyFBagcıA. Predictive value of ATRIA risk score for contrast-induced nephropathy after percutaneous coronary intervention for ST-segment elevation myocardial infarction. Rev Assoc Med Bras (1992). 2019;65:1384–90.
29.
BAĞCI A, Aksoy F, BAŞ HA. Akut koroner sendromda kontrast nefropati gelişimi ile Syntax Skoru arasındaki ilişki. Cukurova Med J. 2019;44:1181–8.
